Corbus Pharmaceuticals Holdings, Inc. (0SZI.L)
USD 14.17
(-0.14%)
USD 14.17
(-0.14%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -10.31 USD | 23.0% |
| 2022 | -13.39 USD | -20.52% |
| 2021 | -11.11 USD | 74.01% |
| 2020 | -42.74 USD | -31.63% |
| 2019 | -32.47 USD | -10.82% |
| 2018 | -29.30 USD | -51.19% |
| 2017 | -19.38 USD | -32.92% |
| 2016 | -14.58 USD | -72.14% |
| 2015 | -8.47 USD | -124.07% |
| 2014 | -3.78 USD | -440.0% |
| 2013 | -0.70 USD | 81.68% |
| 2012 | -3.82 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.83 USD | -35.36% |
| 2024 Q2 | -0.90 USD | -44.9% |
| 2023 Q1 | -4.47 USD | -70.61% |
| 2023 FY | - USD | 23.0% |
| 2023 Q4 | -1.81 USD | 20.26% |
| 2023 Q3 | -2.27 USD | -10.73% |
| 2023 Q2 | -2.05 USD | 54.14% |
| 2022 Q4 | -2.62 USD | -21.86% |
| 2022 Q3 | -2.15 USD | 63.93% |
| 2022 Q2 | -5.96 USD | -124.06% |
| 2022 Q1 | -2.66 USD | -8.13% |
| 2022 FY | - USD | -20.52% |
| 2021 Q1 | -4.14 USD | -39.86% |
| 2021 Q2 | -4.42 USD | -6.76% |
| 2021 Q3 | -0.52 USD | 88.24% |
| 2021 FY | - USD | 74.01% |
| 2021 Q4 | -2.46 USD | -373.08% |
| 2020 Q3 | -12.79 USD | 17.32% |
| 2020 Q2 | -15.47 USD | -20.48% |
| 2020 Q1 | -12.84 USD | -4.14% |
| 2020 FY | - USD | -31.63% |
| 2020 Q4 | -2.96 USD | 76.86% |
| 2019 Q3 | -9.65 USD | -1172.22% |
| 2019 FY | - USD | -10.82% |
| 2019 Q1 | -12.76 USD | -40.68% |
| 2019 Q4 | -12.33 USD | -27.77% |
| 2019 Q2 | 0.90 USD | 107.05% |
| 2018 Q2 | -6.33 USD | -1.77% |
| 2018 Q1 | -6.22 USD | -4.36% |
| 2018 FY | - USD | -51.19% |
| 2018 Q4 | -9.07 USD | -18.41% |
| 2018 Q3 | -7.66 USD | -21.01% |
| 2017 Q3 | -4.16 USD | 4.59% |
| 2017 FY | - USD | -32.92% |
| 2017 Q2 | -4.36 USD | 9.73% |
| 2017 Q4 | -5.96 USD | -43.27% |
| 2017 Q1 | -4.83 USD | 5.66% |
| 2016 Q3 | -3.66 USD | -12.96% |
| 2016 FY | - USD | -72.14% |
| 2016 Q4 | -5.12 USD | -39.89% |
| 2016 Q2 | -3.24 USD | -40.26% |
| 2016 Q1 | -2.31 USD | -16.08% |
| 2015 Q4 | -1.99 USD | -2.58% |
| 2015 Q2 | -2.86 USD | -60.67% |
| 2015 Q1 | -1.78 USD | -21.92% |
| 2015 FY | - USD | -124.07% |
| 2015 Q3 | -1.94 USD | 32.17% |
| 2014 Q4 | -1.46 USD | -89.61% |
| 2014 FY | - USD | -440.0% |
| 2014 Q3 | -0.77 USD | -30.51% |
| 2014 Q2 | -0.59 USD | -353.85% |
| 2014 Q1 | -0.13 USD | 61.76% |
| 2013 Q3 | -0.07 USD | 92.31% |
| 2013 Q1 | -0.29 USD | 0.0% |
| 2013 Q2 | -0.90 USD | -210.34% |
| 2013 Q4 | -0.34 USD | -391.33% |
| 2013 FY | - USD | 81.68% |
| 2012 FY | - USD | 0.0% |